research use only

Uric Acid

Cat.No.S3955

Uric Acid (2,6,8-Trioxypurine, 2,6,8-Trihydroxypurine, 2,6,8-Trioxopurine), a normal component of urine, is a product of the metabolic breakdown of purine nucleotides.
Jump to

Quality Control

Batch: S395501 0.5MNAOH]3.02 mg/mL]false]DMSO]0.01 mg/mL]false]Water]Insoluble]false Purity: 99.99%
99.99

Solubility

In vitro
Batch:

0.5MNAOH : 3.02 mg/mL

DMSO : 0.01 mg/mL (0.05 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 168.11 Formula

C5H4N4O3

Storage (From the date of receipt)
CAS No. 69-93-2 Download SDF Storage of Stock Solutions

Synonyms 2,6,8-Trioxypurine, 2,6,8-Trihydroxypurine, 2,6,8-Trioxopurine SMILES C12=C(NC(=O)N1)NC(=O)NC2=O

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

In vitro
Uric acid activates NFκB in a variety of cell culture models including proximal tubular cells. Uric acid suppresses 1-α hydroxylase mRNA and protein expression in dose dependent and time dependent manner.
In vivo
Uric acid is synthesized mainly in the liver, intestines and the vascular endothelium as the end product of an exogenous pool of purines, and endogenously from damaged, dying and dead cells, whereby nucleic acids, adenine and guanine, are degraded into uric acid. Uric acid is a strong reactive oxygen species (ROS) and peroxynitrite scavenger and antioxidant. Uric acid may exert fundamental roles in tissue healing via initiating the inflammatory process that is necessary for tissue repair, scavenging oxygen free radicals, and mobilizing progenitor endothelial cells.
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-05-29)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07613164 NOT_YET_RECRUITING
Hyperuricemia, Gout
Maanshan Shiqiye Hospital
2026-05
NCT07326839 NOT_YET_RECRUITING
Gout; Obesity
XueMei Guo
2025-12-10
NCT07650214 NOT_YET_RECRUITING
Asymptomatic Hyperuricemia
Sun Yat-sen University
2026-07-01
NCT04026776 RECRUITING
Salt; Excess; Blood Pressure Disorders
Wake Forest University Health Sciences
2020-09-02 EARLY_PHASE1
NCT06824376 RECRUITING
Asymptomatic Hyperuricemia
Shenghao Tu
2025-03-25
NCT06335537 RECRUITING
Uric Acid Stones
University of California, Irvine
2025-05-01 PHASE1

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.